Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Angioplasty
33%
Angiotensin-converting Enzyme Inhibitor (ACEi)
33%
Bradykinin
16%
Cardiac Preconditioning
16%
Cardioprotection
16%
Chest Pain Scores
16%
Coronary Angioplasty
16%
Coronary Blood Flow
16%
Enalaprilat
100%
Human Myocardium
100%
In Vivo Evidence
16%
Inflation
100%
Intracavitary Electrocardiogram
16%
Intracoronary
100%
Intracoronary Infusion
16%
Myocardial Ischemia
16%
Percutaneous Transluminal Coronary Angioplasty
100%
Placebo
16%
Pretreated Patients
16%
Segment Shift
50%
ST Segment
50%
Stable Coronary Artery Disease
16%
Surface Electrocardiogram
33%
Medicine and Dentistry
ACE Inhibitor
33%
Angioplasty
33%
Bioavailability
16%
Bradykinin
16%
Coronary Artery Disease
16%
Coronary Circulation
16%
Electrocardiogram
50%
Enalaprilat
100%
Heart Muscle Ischemia
16%
Infusion
16%
Intracoronary Drug Administration
16%
Myocardium
100%
Placebo
16%
ST Segment
50%
Thorax Pain
16%
Transluminal Coronary Angioplasty
100%
Immunology and Microbiology
Angiotensin
66%
Bradykinin
33%
Coronary Artery
33%
Coronary Artery Blood Flow
33%
Electrocardiogram
100%
Pretreatment
100%
ST Segment
100%
Biochemistry, Genetics and Molecular Biology
Angiotensin-Converting Enzyme
66%
Bradykinin
33%
Coronary Artery Blood Flow
33%
Coronary Artery Disease
33%
Electrocardiogram
100%
Enzyme Inhibitor
66%
ST Segment
100%
Pharmacology, Toxicology and Pharmaceutical Science
Bioavailability
16%
Bradykinin
16%
Coronary Artery Disease
16%
Dipeptidyl Carboxypeptidase Inhibitor
33%
Enalaprilat
100%
Heart Muscle Ischemia
16%
Placebo
16%
Thorax Pain
16%